The EG-UC5T enables to conduct various therapeutic interventional endoscopic procedures under sonographic guidance
SonoScape has secured CE mark approval for its linear-array echoendoscope called EG-UC5T. (Credit: PRNewswire / SonoScape Medical Corporation)
SonoScape, a provider of ultrasound and endoscopy solutions, has secured CE mark approval for its linear-array echoendoscope called EG-UC5T.
The approval of a new linear-array echoendoscope allows to expand the company’s endoscopic ultrasound (EUS) portfolio in the international market.
In September 2019, the company first launched its EUS product line following the CE mark approval of its 360° radial-array echoendoscope known as EG-UR5.
Featuring 4.0mm instrument channel, the EG-UC5T allows users to conduct the adequate tissue sampling and various therapeutic interventional endoscopic procedures under sonographic guidance.
The EG-UC5T is also provided with 12.4-mm insertion diameter, short bending radius and 5-12MHz Accoustic frequency. It consists of light-weight handle with four fully customisable buttons.
SonoScape endoscopy division sales director Steven He said: “SonoScape’s EUS portfolio will certainly extend the company’s path into more and larger hospitals. This again underpins the company’s leading role in the global digestive endoscopy market.
“We have achieved great results with our current gastrointestinal endoscopes, and I am confident that the new linear-array echoendoscopes will set us to a higher success.”
SonoScape stated that it invests around 20% of its revenues into research and development (R&D) in recent three years to launch more advanced products.
The company manages seven R&D centres in Shenzhen, Shanghai, Harbin, Wuhan, Tokyo, Silicon Valley and Seattle.
In September last year, SonoScape unveiled new generation high-end ultrasound systems, the ELITE series.
The systems included artificial intelligent solutions, advanced features, and improved system processing capability.